Literature DB >> 26160397

Feasibility of ultra-low contrast 64-slice computed tomography angiography before transcatheter aortic valve implantation: a real-world experience.

Pietro Spagnolo1, Manuela Giglio2, Daniela Di Marco3, Azeem Latib4, Francesca Besana2, Alaide Chieffo4, Matteo Montorfano4, Sandro Sironi3, Ottavio Alfieri5, Antonio Colombo4.   

Abstract

AIMS: To investigate the feasibility, image quality, and clinical implications of an ultra-low-dose contrast injection computed tomography angiography (CTA) protocol in patients scheduled for transcatheter aortic valve implantation (TAVI). METHODS AND
RESULTS: Images obtained with 64-slice CT were retrospectively evaluated in 162 TAVI candidates with a body mass index (BMI) of ≤29 kg/m(2). A multiphasic, low iodine dose and BMI-adapted CM protocol was administered in all patients (BMI <22 kg/m(2): 40 mL; BMI 22-29 kg/m(2): 55 mL). All images were evaluated for image quality, vessel attenuation, and estimated radiation dose. The anatomy, diameters, perimeter, and area of the aortic annulus were assessed. Anatomy and diameters of peripheral vessels were also evaluated. Image quality of the aortic root and ilio-femoral vessels was diagnostic in all patients. Vascular attenuation was >200 HU at any vessel level. The mean diameters of the aortic annulus were 22 ± 3 mm (range: 16-28 mm) × 26 ± 3 mm (range: 20-33 mm); the mean perimeter was 77.0 ± 7.1 mm. After CTA, a total of 137 patients (84.6%) underwent TAVI. Mean estimated radiation dose was 20.2 ± 4.6 mSv.
CONCLUSION: With our protocol, we achieved images of the aortic annulus and aorto-iliac anatomy of sufficient quality to allow patient selection and procedural planning for TAVI, with a substantial reduction of the amount of injected CM. Published on behalf of the European Society of Cardiology. All rights reserved.
© The Author 2015. For permissions please email: journals.permissions@oup.com.

Entities:  

Keywords:  CT angiography; contrast injection; contrast-induced acute kidney injury; transcatheter aortic valve implantation

Mesh:

Substances:

Year:  2015        PMID: 26160397     DOI: 10.1093/ehjci/jev175

Source DB:  PubMed          Journal:  Eur Heart J Cardiovasc Imaging        ISSN: 2047-2404            Impact factor:   6.875


  5 in total

1.  Prevalence and morphology of myocardial crypts in normal and hypertrophied myocardium by computed tomography.

Authors:  Ziad Arow; Mithal Nassar; Daniel Monakier; Abid Assali; Hana Vaknin-Assa; Ran Kornowski; Ashraf Hamdan
Journal:  Int J Cardiovasc Imaging       Date:  2019-03-05       Impact factor: 2.357

2.  Is MRI equivalent to CT in the guidance of TAVR? A pilot study.

Authors:  Agnes Mayr; Gert Klug; Sebastian J Reinstadler; Hans-Josef Feistritzer; Martin Reindl; Christian Kremser; Christof Kranewitter; Nikolaos Bonaros; Guy Friedrich; Gudrun Feuchtner; Bernhard Metzler
Journal:  Eur Radiol       Date:  2018-05-07       Impact factor: 5.315

3.  Very low intravenous contrast volume protocol for computed tomography angiography providing comprehensive cardiac and vascular assessment prior to transcatheter aortic valve replacement in patients with chronic kidney disease.

Authors:  Todd C Pulerwitz; Omar K Khalique; Tamim N Nazif; Anna Rozenshtein; Gregory D N Pearson; Rebecca T Hahn; Torsten P Vahl; Susheel K Kodali; Isaac George; Martin B Leon; Belinda D'Souza; Ming Jack Po; Andrew J Einstein
Journal:  J Cardiovasc Comput Tomogr       Date:  2016-03-28

Review 4.  Vascular Imaging Before Transcatheter Aortic Valve Replacement (TAVR): Why and How?

Authors:  Damiano Caruso; Russell D Rosenberg; Carlo N De Cecco; Stefanie Mangold; Julian L Wichmann; Akos Varga-Szemes; Daniel H Steinberg; Andrea Laghi; U Joseph Schoepf
Journal:  Curr Cardiol Rep       Date:  2016-02       Impact factor: 2.931

5.  Cardiac magnetic resonance imaging versus computed tomography to guide transcatheter aortic valve replacement: study protocol for a randomized trial (TAVR-CMR).

Authors:  Gert Klug; Sebastian Reinstadler; Felix Troger; Magdalena Holzknecht; Martin Reindl; Christina Tiller; Ivan Lechner; Priscilla Fink; Mathias Pamminger; Christian Kremser; Hanno Ulmer; Axel Bauer; Bernhard Metzler; Agnes Mayr
Journal:  Trials       Date:  2022-09-02       Impact factor: 2.728

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.